Cabaletta Bio, Inc. (CABA)
Cabaletta Bio Market Cap : 201.94M for Nov. 20, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2026 | 201.94M |
| November 19, 2026 | 217.88M |
| November 18, 2026 | 227.58M |
| November 17, 2026 | 220.03M |
| November 16, 2026 | 239.45M |
| November 13, 2026 | 276.12M |
| November 12, 2026 | 286.91M |
| November 11, 2026 | 312.79M |
| November 10, 2026 | 312.79M |
| November 09, 2026 | 323.58M |
| November 06, 2026 | 280.44M |
| November 05, 2026 | 276.12M |
| November 04, 2026 | 306.32M |
| November 03, 2026 | 306.32M |
| November 02, 2026 | 239.85M |
| October 30, 2026 | 253.27M |
| October 29, 2026 | 265.85M |
| October 28, 2026 | 254.94M |
| October 27, 2026 | 244.04M |
| October 26, 2026 | 226.43M |
| October 23, 2026 | 246.56M |
| October 22, 2026 | 254.94M |
| October 21, 2026 | 258.30M |
| October 20, 2026 | 270.04M |
| October 19, 2026 | 248.24M |
| Date | Value |
|---|---|
| October 16, 2026 | 236.49M |
| October 15, 2026 | 259.98M |
| October 14, 2026 | 271.72M |
| October 13, 2026 | 283.46M |
| October 12, 2026 | 300.23M |
| October 09, 2026 | 323.71M |
| October 08, 2026 | 327.07M |
| October 07, 2026 | 330.42M |
| October 06, 2026 | 338.81M |
| October 05, 2026 | 348.87M |
| October 02, 2026 | 335.45M |
| October 01, 2026 | 317.00M |
| September 30, 2026 | 322.03M |
| September 29, 2026 | 332.10M |
| September 28, 2026 | 335.45M |
| September 25, 2026 | 347.19M |
| September 24, 2026 | 361.45M |
| September 23, 2026 | 372.35M |
| September 22, 2026 | 419.32M |
| September 21, 2026 | 412.61M |
| September 18, 2026 | 427.70M |
| September 17, 2026 | 432.73M |
| September 16, 2026 | 417.64M |
| September 15, 2026 | 435.25M |
| September 14, 2026 | 488.08M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Agenus, Inc. | 269.90M |
| Amgen, Inc. | 235.64B |
| Anika Therapeutics, Inc. | 177.20M |
| BioCryst Pharmaceuticals, Inc. | 1.849B |
| Imunon, Inc. | 3.326M |
Market Cap Related Metrics
| Price to Book Value | 0.7112 |
| Price | 0.9361 |
| Earnings Yield | -152.5% |